Highlights Moderna, Inc.

Equities

MRNA

US60770K1079

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 16:00:00 2025-07-18 EDT			5-day change	1st Jan Change
31.26 ^USD	-2.92%		-7.07%	-24.82%

07-18	Moderna Completes Research Facility in Japan, Scraps mRNA Manufacturing Base	MT
07-18	Moderna Cancels Plan to Construct mRNA Facility in Japan	MT

Highlights

US FDA approves pre-filled version of GSK's shingles vaccine	07-17	RE
Top Midday Stories: MP Materials Partners With DoD on Rare Earth Magnet Supply Chain; Delta Restores Full-Year Guidance	07-10	MT
Moderna Wins US FDA Clearance for Updated COVID-19 Vaccine for At-risk Children	07-10	MT
Pfizer, BioNTech Appeal London Court Ruling Over Moderna mRNA Patent Dispute	07-10	MT
Moderna Receives FDA Approval for Spikevax Vaccine in Children Aged Six Months to 11 Years	07-10	MT
Moderna gets full US approval for COVID shot in at-risk children 6 months and older	07-10	RE
Moderna gets full US approval for COVID-19 vaccine in children 6 months and older	07-10	RE
Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win	07-10	RE
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday	06-30	MT
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday Amid Hopes of Smoother Canada Relations	06-30	MT
Moderna: positive efficacy data for influenza	06-30
Kennedy's US vaccine panel backs preservative-free shot despite safety evidence	06-26	RE
US Health Secretary Kennedy's vaccine actions and policy positions	06-25	RE
US CDC vaccine presentation cites study that does not exist, author says	06-24	RE
US CDC vaccine presentation cites study that does not exist, author says	06-24	RE
US CDC's report shows no evidence linking thimerosal-containing vaccines and autism	06-24	RE
Kennedy's new US vaccine panel to discuss measles shot for children	06-18	RE
Kennedy's new US vaccine panel to discuss measles shot for children	06-18	RE
CDC's vaccine advisory committee to vote on RSV, flu shots	06-18	RE
Sixth Street-backed Caris lifts IPO price range, eyes $5.7 billion valuation	06-16	RE
GSK applies to EU regulator for expanded use of RSV vaccine	06-13	RE
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults	06-12	RE
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults	06-12	RE
Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents	06-11	RE
Novavax's COVID-flu combo vaccine shows strong immune response in trial	06-11	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna struggles to convince the market

June 23, 2025 at 04:59 am

Moderna Reports Another Quarterly Loss

February 14, 2025 at 04:24 pm